{{Rsnum
|rsid=11753937
|Gene=EYA4
|Chromosome=6
|position=133342451
|Orientation=plus
|GMAF=0.2098
|Gene_s=EYA4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 45.1 | 45.1 | 9.7
| HCB | 77.2 | 22.1 | 0.7
| JPT | 62.8 | 31.9 | 5.3
| YRI | 100.0 | 0.0 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 77.2 | 22.1 | 0.7
| CHD | 68.8 | 27.5 | 3.7
| GIH | 61.4 | 33.7 | 5.0
| LWK | 90.0 | 6.4 | 3.6
| MEX | 65.5 | 29.3 | 5.2
| MKK | 66.7 | 28.2 | 5.1
| TSI | 43.1 | 42.2 | 14.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22566498
|Trait=None
|Title=Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
|RiskAllele=T
|Pval=0.000006
|OR=1.1200
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}